Venturing into TechBio: VC Insights for Deep Tech Startups | Deep Tech Catalyst

Welcome to the 70th edition of Deep Tech Catalyst, the channel by The Scenarionist, where science meets venture!

---

✨ For more, see Membership | Deep Tech Briefing | Venture Guides

---

In this episode of Deep Tech Catalyst, we dive into the evolving landscape of TechBio—a space where biology meets artificial intelligence and startups are reimagining how we discover and develop new therapies.

We’re thrilled to welcome Shelby Newsad, Partner at Compound and one of the sharpest minds operating at the intersection of AI and biology!

Together, we explore what defines a TechBio company, how technical and scientific talent converge in this new generation of startups, and what it takes to build an investable business in this space.

From data infrastructure to clinical timelines, and from team formation to exit strategy, this conversation breaks down the real-world dynamics of launching and scaling a TechBio venture.

Let’s dive in. 🎯

---

BEYOND THE CONVERSATION — STRATEGIC INSIGHTS FROM THE EPISODE

---

Keep reading. It’s free.

---

Disclaimer

All materials published by The Scenarionist are provided solely for informational and educational purposes. They do not constitute financial, legal, or tax advice, nor do they constitute a recommendation, offer, or solicitation to buy or sell securities, crypto assets, or any other assets. The Scenarionist strives to provide accurate information but does not guarantee that its materials are complete, current, or free from errors, and assumes no liability for any reliance placed on them. Any external partnership or sponsored content will be clearly identified as “Brought to you by.” Unless otherwise disclosed, the companies and technologies mentioned do not sponsor The Scenarionist and are not included in its investment holdings. Artificial intelligence tools may be used for operational support and content refinement.